Since 2023, the U.S. Food and Drug Administration (FDA) has not required animal testing, thanks in part to organoids, which ...

Researchers at Moffitt Cancer Center have developed a novel biomaterial-based system that induces the formation of tertiary ...

Researchers at Moffitt Cancer Center have developed a novel biomaterial-based system that induces the formation of tertiary ...

Immix Biopharma, Inc. is building strength in its pipeline with impressive early signals in AL amyloidosis. Learn more about ...

Another common feature: Patients with a number of autoimmune diseases, especially women, often suffer heart attacks and ...

It's unclear if these changes persist beyond the four weeks limited by the trial period, or what they mean for a person's ...

A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...

Once thought to be a flaw in the system, new research suggests that CD4 T cells may actually hold the key to maintaining a ...

Mayo Clinic researchers have developed a pioneering method to mend damaged hearts without open-heart surgery, an advance that could one day transform the treatment of heart failure.

Researchers at Moffitt Cancer Center have developed a novel biomaterial-based system that induces the formation of tertiary lymphoid-like structures, or TLSs. These immune cell clusters are ...

Researchers have uncovered how the brain’s immune cells, called microglia, can act as protectors rather than destroyers in Alzheimer’s disease.

Researchers at Weill Cornell Medicine have uncovered a new clue in understanding how dementia develops—and their discovery ...